Literature DB >> 18372012

Multi-drug-resistant bacteremia after transrectal ultrasound guided prostate biopsies in hospital employees and their relatives.

Ciamack Kamdar1, Unni M M Mooppan, Frederick A Gulmi, Hong Kim.   

Abstract

OBJECTIVES: To evaluate the incidence of multi-drug-resistant (MDR) organisms causing bacteremia in hospital employees and their relatives after transrectal ultrasound (TRUS) guided prostate biopsies.
METHODS: We retrospectively reviewed all TRUS-guided prostate biopsies between November 2006 and November 2007. Of the 378 patients, we identified 4 cases of post-procedure bacteremia requiring hospital admission. All 4 of these patients had MDR organisms causing bacteremia. These patients were then contacted to determine whether they or their relatives were hospital employees.
RESULTS: We identified 4 patients among a total of 378 who developed MDR bacteremia after TRUS prostate biopsy (1.06%). Three of these patients or their relatives were hospital employees (75%). All 3 of these patients had bacteremia caused by Escherichia coli that was resistant to ciprofloxacin and levofloxacin, the perioperative antibiotic given.
CONCLUSIONS: In addition to the standard TRUS biopsy preoperative questions it is beneficial to ask patients whether they are hospital employees or live in the same household as hospital employees. This way, if patients return postoperatively with fever and chills, there is a higher index of suspicion that bacteremia may be caused by MDR organisms and empiric broad spectrum parenteral antibiotics can be started immediately.

Entities:  

Mesh:

Year:  2008        PMID: 18372012     DOI: 10.1016/j.urology.2008.01.065

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  8 in total

1.  Catastrophic sepsis and hemorrhage following transrectal ultrasound guided prostate biopsies.

Authors:  Paul Toren; Roshan Razik; John Trachtenberg
Journal:  Can Urol Assoc J       Date:  2010-02       Impact factor: 1.862

Review 2.  Cutting to the Core of the Issue: Emerging Strategies To Reduce Prostate Biopsy-Related Infections.

Authors:  Robin R Chamberland
Journal:  J Clin Microbiol       Date:  2016-05-04       Impact factor: 5.948

3.  Reducing Infectious Complications Following Transrectal Ultrasound-guided Prostate Biopsy: A Systematic Review.

Authors:  Jordon T Walker; Nirmish Singla; Claus G Roehrborn
Journal:  Rev Urol       Date:  2016

4.  Prospective Monitoring and Adapting Strategies for Prevention of Infection Following Transrectal Prostate Procedures.

Authors:  Solomon L Woldu; Ryan C Hutchinson; Nirmish Singla; Brad Hornberger; Claus G Roehrborn; Yair Lotan
Journal:  Urol Pract       Date:  2017-03-18

5.  Prospective study of antibiotic prophylaxis for prostate biopsy involving >1100 men.

Authors:  Rustom P Manecksha; Gregory J Nason; Ivor M Cullen; Jérôme P Fennell; Elizabeth McEvoy; Ted McDermott; Robert J Flynn; Ronald Grainger; John A Thornhill
Journal:  ScientificWorldJournal       Date:  2012-05-02

6.  Infections after fiducial marker implantation for prostate radiotherapy: are we underestimating the risks?

Authors:  Jasmin Loh; Katie Baker; Swetha Sridharan; Peter Greer; Chris Wratten; Anne Capp; Sarah Gallagher; Jarad Martin
Journal:  Radiat Oncol       Date:  2015-02-13       Impact factor: 3.481

7.  Rectal Culture-Guided Targeted Antimicrobial Prophylaxis Reduces the Incidence of Post-Operative Infectious Complications in Men at High Risk for Infections Submitted to Transrectal Ultrasound Prostate Biopsy - Results of a Cross-Sectional Study.

Authors:  Luca Boeri; Matteo Fontana; Andrea Gallioli; Stefano Paolo Zanetti; Michele Catellani; Fabrizio Longo; Barbara Mangiarotti; Emanuele Montanari
Journal:  PLoS One       Date:  2017-01-25       Impact factor: 3.240

Review 8.  Strategies for prevention of ultrasound-guided prostate biopsy infections.

Authors:  Diane D Lu; Jay D Raman
Journal:  Infect Drug Resist       Date:  2016-07-08       Impact factor: 4.003

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.